Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Genitourinary Cancers
•
Pediatric Oncology
•
Medical Oncology
•
Testicular Cancer
•
NCI-CCC Tumor Board Question
•
AYA
•
Johns Hopkins
•
NCI-CCC GU Tumor Board Question
Do you treat stage 1 non-seminoma differently if there is a component of embryonal carcinoma?
Answer from: Medical Oncologist at Academic Institution
No.
Sign in or Register to read more
12828
Related Questions
Would you consider a cycle of EP in a patient with good risk stage IIIB seminoma on BEP but with bleomycin omitted for cycle 3?
How would you treat a patient with Hodgkin lymphoma who has an isolated relapse within the CNS?
How would you treat a stage IIIB recurrent seminoma with early recurrence following first-line treatment with VIP?
What is your approach to systemic treatment of de novo metastatic hormone-sensitive prostate ductal adenocarcinoma with lung only metastases?
In a patient with metastatic RCC who discontinued nivolumab after a prolonged response to ipilimumab/nivolumab, would you consider re-starting nivolumab at disease progression?
Would you extrapolate from EMBARK to use an ARPI other than enzalutamide in high risk biochemically recurrent prostate cancer for a patient with contraindications to enzalutamide?
How would manage a patient with primary mediastinal NSGCT who has radiographic response but rising AFP while receiving VIP?
How would you treat a patient with ESRD on hemodialysis with good risk metastatic seminoma with bulky retroperitoneal adenopathy?
What is the optimal management of malignant mesothelioma of the tunica vaginalis testis (MMTVT) found incidentally after hydrocelectomy?
Is there a concern for the potential of future congenital malformations in offspring when preservation of eggs and sperm is done AFTER cyclophosphamide treatment given that it is an alkylating agent?